Neuren Pharmaceuticals | NEU - Cash And Equivalent



Neuren Pharmaceuticals reported AUD3.15M in Cash and Equivalent for its fiscal semester ending in December of 2024.


Cash And Equivalent Change Date
Alaunos Therapeutics USD 1.09M 592K Dec/2024
Avita Medical AUD 14.05M 3.4M Dec/2024
Clinuvel Pharmaceuticals AUD 35.2M 3.62M Jun/2024
Dianthus Therapeutics USD 13.24M 9.56M Jun/2025
Genetic Signatures AUD 40.79M 4.54M Dec/2024
Ionis Pharmaceuticals USD 297.3M 33.11M Jun/2025
Medical Developments International AUD 17.62M 7.88M Dec/2024
Neuren Pharmaceuticals AUD 3.15M 582K Dec/2024
Organon & Co USD 599M 52M Jun/2025
Paradigm Biopharmaceuticals 17.82M 15.73M Jun/2024
PYC Therapeutics AUD 49.25M 17.62M Dec/2024
Starpharma Holdings AUD 20.28M 3.08M Dec/2024
Tectonic Therapeutic USD 287.38M 146.14M Jun/2025
Telix Pharmaceuticals 710.35M 587.11M Dec/2024
Viatris USD 566.4M 188.6M Jun/2025
Xeris Pharmaceuticals USD 59.28M 12.34M Jun/2025